Alyeska Investment Group
CFRX

Alyeska Investment Group’s ContraFect Corporation CFRX Stock Holding History

Alyeska Investment Group’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,125
Closed -$1.1M – 890
2021
Q2 		$1.1M Hold
3,125
– – 0.01% 574
2021
Q1 		$1.2M Buy
+3,125
New +$1.35M 0.02% 540
2018
Q1 		– Sell
-1,643
Closed -$2.03M – 549
2017
Q4 		$1.33M Sell
1,643
-120
-7% -$99.2K 0.01% 367
2017
Q3 		$1.56M Buy
1,763
+902
+105% +$853K 0.01% 385
2017
Q2 		$999K Sell
861
-30
-3% -$35.2K 0.01% 409
2017
Q1 		$1.28M Sell
891
-89
-9% -$140K 0.01% 426
2016
Q4 		$1.37M Sell
980
-116
-11% -$205K 0.01% 414
2016
Q3 		$2.17M Buy
+1,096
New +$2.15M 0.02% 381

Other funds holding CFRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group's CFRX Position: Q3 2021 in Review

Alyeska Investment Group sold out of ContraFect Corporation (CFRX) in Q3 2021, closing a stake of 3,125 shares — an estimated $1.1M sold.

Alyeska Investment Group first reported a position in CFRX in Q3 2016 and held it in 8 quarters. The position peaked at $2.17M in Q3 2016. 56 funds tracked by Wall St. Rank hold CFRX as of Q3 2021.

  • Alyeska Investment Group reported no remaining ContraFect Corporation position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 3,125 ContraFect Corporation shares in Q3 2021, an estimated $1.1M.
  • Alyeska Investment Group first reported a position in ContraFect Corporation in Q3 2016 and held it in 8 quarters.
  • Alyeska Investment Group's ContraFect Corporation position peaked at $2.17M in Q3 2016.
  • 56 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.